Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26FW3R1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,427
Award facts
- Contract value 100% obligated
- $43,426.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $43,426.62 delivery order to AmerisourceBergen Drug Corp on July 10, 2026, for Dupixent 300 mg/2 ml syringes. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V indefinite delivery contract (SPE2DX), a single-award IDC supporting pharmaceutical supply to military healthcare systems worldwide. Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of July 13, 2026.
Quick answers
Who was awarded contract SPE2DR26FW3R1?
SPE2DR26FW3R1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2026.
How much is contract SPE2DR26FW3R1 worth?
The government has obligated $43,427 on SPE2DR26FW3R1.
Is contract SPE2DR26FW3R1 an order under another contract?
Yes. SPE2DR26FW3R1 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FW3R1 competed?
The extent of competition for SPE2DR26FW3R1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award